These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6279968)

  • 1. Growth inhibitory effects of thyroid hormones on androgen-dependent mammary tumor cells.
    Natoli C; Sica G; Natoli V; Scambia G; Iacobelli S
    J Steroid Biochem; 1981 Dec; 15():409-13. PubMed ID: 6279968
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of thyroid hormones on androgen responsiveness in a mammary tumor cell line.
    Sica G; Natoli C; Marchetti P; Iacobelli S
    J Steroid Biochem; 1981 Dec; 15():415-9. PubMed ID: 7339270
    [No Abstract]   [Full Text] [Related]  

  • 3. Nuclear thyroid hormone receptors in a human breast cancer cell line.
    Burke RE; McGuire WL
    Cancer Res; 1978 Nov; 38(11 Pt 1):3769-73. PubMed ID: 212177
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitory effect of a somatostatin analogue (SMS 201-995) on the growth of androgen-dependent mouse mammary tumor (Shionogi carcinoma 115).
    Noguchi S; Nishizawa Y; Motomura K; Inaji H; Imaoka S; Koyama H; Matsumoto K
    Jpn J Cancer Res; 1993 Jun; 84(6):656-63. PubMed ID: 8340254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in sensitivity to cyclophosphamide of mouse mammary tumors during serial transplantation.
    Sluyser M; De Goeij CC; Evers SG
    J Natl Cancer Inst; 1981 Feb; 66(2):327-30. PubMed ID: 6935481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of androgen-sensitive mouse tumor (Shionogi carcinoma 115) to androgen-insensitive tumor after long-term removal of testosterone.
    Sato N; Watabe Y; Suzuki H; Shimazaki J
    Jpn J Cancer Res; 1993 Dec; 84(12):1300-8. PubMed ID: 8294220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The loss of androgen-dependency and its molecular mechanism].
    Sato B; Nakamura N; Nonomura N; Matsumoto K
    Gan No Rinsho; 1989 May; Spec No():261-7. PubMed ID: 2689666
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple sensitivities of mammary tumor cells in culture.
    Yates J; King RJ
    Cancer Res; 1978 Nov; 38(11 Pt 2):4135-7. PubMed ID: 568030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of androgen depletion on growth and androgen dependency of Shionogi carcinoma 115.
    Kitamura Y; Okamoto S; Uchida N; Yamaguchi K; Matsumoto K
    Cancer Res; 1978 Dec; 38(12):4711-6. PubMed ID: 719647
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of estrogen and antiestrogen action in mammary cancer.
    Katzenellenbogen BS; Rorke EA; Eckert RL
    J Steroid Biochem; 1981 Dec; 15():219-29. PubMed ID: 7339248
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of thyroid hormone on androgen- or basic fibroblast growth factor-induced proliferation of Shionogi carcinoma 115 mouse mammary carcinoma cells in serum-free culture.
    Sumitani S; Kasayama S; Hirose T; Matsumoto K; Sato B
    Cancer Res; 1991 Aug; 51(16):4323-7. PubMed ID: 1868455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone receptors in mouse mammary tumors.
    Sluyser M
    Biochim Biophys Acta; 1979 Dec; 560(4):509-29. PubMed ID: 229907
    [No Abstract]   [Full Text] [Related]  

  • 13. Steroid hormones and cancer: (II) Lessons from experimental systems.
    Miller WR; Langdon SP
    Eur J Surg Oncol; 1997 Feb; 23(1):72-83. PubMed ID: 9066752
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant chemo-endocrine therapy for androgen-dependent mammary tumor in mice.
    Uchida N; Yamaguchi K; Narita N; Nakao K; Kitamura Y; Matsumoto K
    Breast Cancer Res Treat; 1981; 1(1):69-75. PubMed ID: 7348566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of different steroid hormones during progression of tumour cells to steroid autonomy.
    Darbre PD; King RJ
    Int J Cancer; 1987 Dec; 40(6):802-6. PubMed ID: 2826338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaP.
    Esquenet M; Swinnen JV; Heyns W; Verhoeven G
    Mol Cell Endocrinol; 1995 Mar; 109(1):105-11. PubMed ID: 7540569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models.
    Gravina GL; Marampon F; Giusti I; Carosa E; Di Sante S; Ricevuto E; Dolo V; Tombolini V; Jannini EA; Festuccia C
    Int J Oncol; 2012 Mar; 40(3):711-20. PubMed ID: 22134754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone-dependent mammary tumors in mice and rats as a model for human breast cancer (review).
    Briand P
    Anticancer Res; 1983; 3(4):273-81. PubMed ID: 6309070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A test for hormonal responsiveness in a mammary epithelial cell line, NMuMg.
    Sizemore SR; Cole RD
    In Vitro; 1982 Aug; 18(8):668-74. PubMed ID: 6290375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Breast cancer and its hormonal dependency].
    Matsumoto K; Sato B
    Gan No Rinsho; 1989 May; Spec No():204-11. PubMed ID: 2689662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.